Assignee
SCRIBE THERAPEUTICS INC
US11 patents
Top patents by PatentIndex Score
US11560555B2Jan 24, 2023
Engineered proteins
SCRIBE THERAPEUTICS INC15 citations91
US12084692B2Sep 10, 2024
Guide scaffolds
SCRIBE THERAPEUTICS INC5 citations82
US11535835B1Dec 27, 2022
Compositions and methods for the targeting of rhodopsin
SCRIBE THERAPEUTICS INC7 citations82
US11613742B2Mar 28, 2023
Compositions and methods for the targeting of SOD1
SCRIBE THERAPEUTICS INC4 citations71
US12163125B2Dec 10, 2024
Engineered class 2 type V CRISPR systems
SCRIBE THERAPEUTICS INC5 citations70
US11976277B2May 7, 2024
Particle delivery systems
SCRIBE THERAPEUTICS INC3 citations69
US12551560B2Feb 17, 2026
Compositions and methods for use in immunotherapy
SCRIBE THERAPEUTICS INC0 citations59
US12559743B2Feb 24, 2026
Engineered guide scaffolds
SCRIBE THERAPEUTICS INC0 citations58
US12553037B2Feb 17, 2026
Engineered class 2, type V repressor systems
SCRIBE THERAPEUTICS INC0 citations56
US12594349B2Apr 7, 2026
Compositions and methods for the targeting of PCSK9
SCRIBE THERAPEUTICS INC0 citations55
US12551573B2Feb 17, 2026
Compositions and methods for the targeting of PCSK9
SCRIBE THERAPEUTICS INC0 citations55